{"transactions":[{"id":737663,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:12:13.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001437749-26-020705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020705/rdgdoc.xml","form_type":"4"}},{"id":772915,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T00:49:55.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":5937,"source":{"system":"sec-edgar","filing":"0000905148-26-002533","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514826002533/form4.xml","form_type":"4"}},{"id":922583,"issuer":{"id":2423,"kind":"organization","name":"RIGEL PHARMACEUTICALS INC","symbol":"RIGL"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-02-03T21:09:48.000Z","date":"2026-02-01","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in equal monthly installments over a period beginning on February 1, 2026 and ending on the date of the annual meeting at which the Reporting Person is first scheduled to be considered for election by the stockholders, subject to the Reporting Person's continuous service on the Company's Board of Directors."}],"balance_after":12000,"derivative":{"exercise_price":34.86,"expiration_date":"2036-02-01","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000905148-26-000482","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034842/000090514826000482/form4.xml","form_type":"4"}},{"id":940864,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T00:02:53.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":2.01,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-26-002976","document":"tm262917-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000110465926002976/tm262917-3_4seq1.xml","form_type":"4"}},{"id":1000091,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-13T21:41:21.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":4.8614,"value":97228.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $4.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-25-034874","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925034874/rdgdoc.xml","form_type":"4"}},{"id":1111411,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:19:53.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":74000,"source":{"system":"sec-edgar","filing":"0001437749-25-020363","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020363/rdgdoc.xml","form_type":"4"}},{"id":1434731,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-14T01:09:49.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":23358,"price":3.4877,"value":81465.6966,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4201 to $3.5501, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Corrects the amount that was erroneously reported as held in the Form 4 filed on June 21, 2024 with the Securities and Exchange Commission."}],"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001437749-24-026536","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924026536/rdgdoc.xml","form_type":"4"}},{"id":1471916,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:21:21.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":95358,"source":{"system":"sec-edgar","filing":"0001437749-24-021018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021018/rdgdoc.xml","form_type":"4"}},{"id":1483214,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T23:00:40.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":1.44,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-24-070515","document":"tm2416928-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000110465924070515/tm2416928-2_4seq1.xml","form_type":"4"}},{"id":1745633,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-09T21:19:04.000Z","date":"2023-11-07","kind":"sale","planned":false,"acquired":false,"shares":25000,"price":2.8321,"value":70802.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7801 to $2.8801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":43358,"source":{"system":"sec-edgar","filing":"0001437749-23-031275","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923031275/rdgdoc.xml","form_type":"4"}},{"id":1842603,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-28T20:59:51.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":17.52,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-23-075868","document":"tm2319786-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000110465923075868/tm2319786-2_4seq1.xml","form_type":"4"}},{"id":1854147,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T00:28:13.000Z","date":"2023-06-13","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":68358,"source":{"system":"sec-edgar","filing":"0001437749-23-017594","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017594/rdgdoc.xml","form_type":"4"}},{"id":1854146,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-16T00:28:13.000Z","date":"2023-06-13","kind":"sale","planned":true,"acquired":false,"shares":13500,"price":3.4541,"value":46630.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":41358,"source":{"system":"sec-edgar","filing":"0001437749-23-017594","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923017594/rdgdoc.xml","form_type":"4"}},{"id":2189269,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-10T22:01:43.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":25000,"price":3.5517,"value":88792.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4828 to $3.6700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":54858,"source":{"system":"sec-edgar","filing":"0001437749-22-019857","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922019857/rdgdoc.xml","form_type":"4"}},{"id":2214330,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-06T01:04:11.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three substantially equal annual installments following the date of grant, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":14.27,"expiration_date":"2032-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-077473","document":"tm2220442-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000110465922077473/tm2220442-1_4seq1.xml","form_type":"4"}},{"id":2229838,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-16T22:56:23.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":79858,"source":{"system":"sec-edgar","filing":"0001437749-22-015212","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922015212/rdgdoc.xml","form_type":"4"}},{"id":2327016,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-03-17T20:33:29.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":25653,"price":2.7986,"value":71792.4858,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.78 to $2.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52858,"source":{"system":"sec-edgar","filing":"0001437749-22-006597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922006597/rdgdoc.xml","form_type":"4"}},{"id":2663416,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-17T23:38:42.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":27858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":78511,"source":{"system":"sec-edgar","filing":"0001209191-21-041731","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121041731/doc4.xml","form_type":"4"}},{"id":3113227,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-12T00:04:00.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":50653,"source":{"system":"sec-edgar","filing":"0001209191-20-036122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120036122/doc4.xml","form_type":"4"}},{"id":3210702,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2020-03-13T22:46:48.000Z","date":"2020-03-12","kind":"sale","acquired":false,"shares":1500,"price":102.17,"value":153255.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22118,"source":{"system":"sec-edgar","filing":"0001765581-20-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558120000045/edgardoc.xml","form_type":"4"}},{"id":3220163,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2020-03-09T23:03:44.000Z","date":"2020-03-05","kind":"tax_withholding","acquired":false,"shares":2423,"price":124.5,"value":301663.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":23618,"source":{"system":"sec-edgar","filing":"0001765581-20-000034","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558120000034/edgardoc.xml","form_type":"4"}},{"id":3245997,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2020-02-26T22:09:43.000Z","date":"2020-02-25","kind":"tax_withholding","acquired":false,"shares":530,"price":127.25,"value":67442.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":26041,"source":{"system":"sec-edgar","filing":"0001765581-20-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558120000012/edgardoc.xml","form_type":"4"}},{"id":3270237,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2020-02-14T22:39:27.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":1500,"price":142.18,"value":213270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":26571,"source":{"system":"sec-edgar","filing":"0001765581-20-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558120000010/edgardoc.xml","form_type":"4"}},{"id":3310671,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2020-01-15T21:11:11.000Z","date":"2020-01-13","kind":"sale","acquired":false,"shares":1500,"price":146.78,"value":220170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":28071,"source":{"system":"sec-edgar","filing":"0001765581-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558120000006/edgardoc.xml","form_type":"4"}},{"id":3346425,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-12-10T23:06:54.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":1500,"price":149.12,"value":223680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2019."}],"balance_after":29571,"source":{"system":"sec-edgar","filing":"0001765581-19-000102","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000102/edgardoc.xml","form_type":"4"}},{"id":3492557,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-06-13T00:37:52.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":19423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":24905,"source":{"system":"sec-edgar","filing":"0001209191-19-036572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919119036572/doc4.xml","form_type":"4"}},{"id":3496910,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-06-07T20:46:57.000Z","date":"2019-06-05","kind":"tax_withholding","acquired":false,"shares":123,"price":130.4,"value":16039.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 140 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2019."}],"balance_after":31039,"source":{"system":"sec-edgar","filing":"0001765581-19-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000049/edgardoc.xml","form_type":"4"}},{"id":3605954,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:09:16.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":648,"price":135.82,"value":88011.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":31022,"source":{"system":"sec-edgar","filing":"0001765581-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000037/edgardoc.xml","form_type":"4"}},{"id":3605953,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-08T00:09:16.000Z","date":"2019-03-05","kind":"tax_withholding","acquired":false,"shares":833,"price":135.82,"value":113138.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":31670,"source":{"system":"sec-edgar","filing":"0001765581-19-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000037/edgardoc.xml","form_type":"4"}},{"id":3618459,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-03-05T00:36:51.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":20286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":20286,"derivative":{"exercise_price":140.03,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":20286},"source":{"system":"sec-edgar","filing":"0001765581-19-000021","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000021/edgardoc.xml","form_type":"4"}},{"id":3618458,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-03-05T00:36:51.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":714,"derivative":{"exercise_price":140.03,"expiration_date":"2029-02-27","underlying":"Ordinary Shares","underlying_shares":714},"source":{"system":"sec-edgar","filing":"0001765581-19-000021","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000021/edgardoc.xml","form_type":"4"}},{"id":3618457,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-03-05T00:36:51.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":32503,"source":{"system":"sec-edgar","filing":"0001765581-19-000021","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000021/edgardoc.xml","form_type":"4"}},{"id":3628713,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-02-27T23:38:34.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":414,"price":127.76,"value":52892.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":24103,"source":{"system":"sec-edgar","filing":"0001765581-19-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000008/edgardoc.xml","form_type":"4"}},{"id":3628712,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2019-02-27T23:38:34.000Z","date":"2019-02-25","kind":"tax_withholding","acquired":false,"shares":528,"price":126.25,"value":66660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2018."}],"balance_after":24517,"source":{"system":"sec-edgar","filing":"0001765581-19-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000176558119000008/edgardoc.xml","form_type":"4"}},{"id":3764385,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-11-15T01:08:10.000Z","date":"2018-11-13","kind":"sale","acquired":false,"shares":200,"price":149.27,"value":29854.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":24972,"source":{"system":"sec-edgar","filing":"0001232524-18-000194","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000194/edgardoc.xml","form_type":"4"}},{"id":3789736,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-10-16T20:28:28.000Z","date":"2018-10-12","kind":"sale","acquired":false,"shares":200,"price":158.46,"value":31692.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25172,"source":{"system":"sec-edgar","filing":"0001232524-18-000178","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000178/edgardoc.xml","form_type":"4"}},{"id":3814055,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-09-17T22:06:54.000Z","date":"2018-09-14","kind":"sale","acquired":false,"shares":200,"price":165.2,"value":33040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25372,"source":{"system":"sec-edgar","filing":"0001232524-18-000169","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000169/edgardoc.xml","form_type":"4"}},{"id":3841506,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-08-16T20:52:52.000Z","date":"2018-08-14","kind":"sale","acquired":false,"shares":200,"price":175.7,"value":35140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25572,"source":{"system":"sec-edgar","filing":"0001232524-18-000162","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000162/edgardoc.xml","form_type":"4"}},{"id":3866071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-07-17T20:44:30.000Z","date":"2018-07-13","kind":"sale","acquired":false,"shares":200,"price":179.15,"value":35830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25772,"source":{"system":"sec-edgar","filing":"0001232524-18-000119","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000119/edgardoc.xml","form_type":"4"}},{"id":3890474,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-06-18T20:37:54.000Z","date":"2018-06-14","kind":"sale","acquired":false,"shares":200,"price":176.53,"value":35306.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":25972,"source":{"system":"sec-edgar","filing":"0001232524-18-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000113/edgardoc.xml","form_type":"4"}},{"id":3893661,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-14T22:36:19.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5482,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":5482,"source":{"system":"sec-edgar","filing":"0001209191-18-037867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118037867/doc4.xml","form_type":"4"}},{"id":3901385,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-06-07T20:42:15.000Z","date":"2018-06-05","kind":"tax_withholding","acquired":false,"shares":123,"price":172.54,"value":21222.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 173 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2018."}],"balance_after":26172,"source":{"system":"sec-edgar","filing":"0001232524-18-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000111/edgardoc.xml","form_type":"4"}},{"id":3932641,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-05-15T21:24:50.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":200,"price":164.68,"value":32936.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":26122,"source":{"system":"sec-edgar","filing":"0001232524-18-000101","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000101/edgardoc.xml","form_type":"4"}},{"id":3940737,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-05-09T20:22:19.000Z","date":"2018-05-07","kind":"tax_withholding","acquired":false,"shares":1159,"price":147.03,"value":170407.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":26322,"source":{"system":"sec-edgar","filing":"0001232524-18-000096","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000096/edgardoc.xml","form_type":"4"}},{"id":3963923,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-04-13T21:22:36.000Z","date":"2018-04-13","kind":"sale","acquired":false,"shares":200,"price":157.49,"value":31498.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27481,"source":{"system":"sec-edgar","filing":"0001232524-18-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000078/edgardoc.xml","form_type":"4"}},{"id":3992083,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-16T21:10:38.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":200,"price":151.12,"value":30224.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":27681,"source":{"system":"sec-edgar","filing":"0001232524-18-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000070/edgardoc.xml","form_type":"4"}},{"id":4007845,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-07T21:11:42.000Z","date":"2018-03-05","kind":"tax_withholding","acquired":false,"shares":648,"price":143.39,"value":92916.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":27881,"source":{"system":"sec-edgar","filing":"0001232524-18-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000063/edgardoc.xml","form_type":"4"}},{"id":4014411,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-05T21:30:27.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":19290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":19290,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":19290},"source":{"system":"sec-edgar","filing":"0001232524-18-000045","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000045/edgardoc.xml","form_type":"4"}},{"id":4014410,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2018-03-05T21:30:27.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":710,"derivative":{"exercise_price":140.67,"expiration_date":"2028-02-29","underlying":"Ordinary Shares","underlying_shares":710},"source":{"system":"sec-edgar","filing":"0001232524-18-000045","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000045/edgardoc.xml","form_type":"4"}},{"id":4014409,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-03-05T21:30:27.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2018, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":28529,"source":{"system":"sec-edgar","filing":"0001232524-18-000045","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000045/edgardoc.xml","form_type":"4"}},{"id":4026798,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-02-28T22:27:22.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":940,"price":147.44,"value":138593.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":20529,"source":{"system":"sec-edgar","filing":"0001232524-18-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000028/edgardoc.xml","form_type":"4"}},{"id":4029979,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-27T22:30:03.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":17626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is February 23, 2018. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":17626,"derivative":{"exercise_price":68.25,"expiration_date":"2028-02-22","underlying":"Common Stock","underlying_shares":17626},"source":{"system":"sec-edgar","filing":"0001209191-18-014045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118014045/doc4.xml","form_type":"4"}},{"id":4051478,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-02-16T22:31:48.000Z","date":"2018-02-14","kind":"sale","acquired":false,"shares":200,"price":139.99,"value":27998.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":21469,"source":{"system":"sec-edgar","filing":"0001601583-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000160158318000004/edgardoc.xml","form_type":"4"}},{"id":4097637,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2018-01-17T21:55:17.000Z","date":"2018-01-12","kind":"sale","acquired":false,"shares":200,"price":148.65,"value":29730.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":21669,"source":{"system":"sec-edgar","filing":"0001232524-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252418000004/edgardoc.xml","form_type":"4"}},{"id":4133159,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-12-13T22:56:28.000Z","date":"2017-12-11","kind":"sale","acquired":false,"shares":200,"price":139.15,"value":27830.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2017."}],"balance_after":21869,"source":{"system":"sec-edgar","filing":"0001232524-17-000187","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000187/edgardoc.xml","form_type":"4"}},{"id":4232155,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-08-16T23:17:04.000Z","date":"2017-08-15","kind":"sale","acquired":false,"shares":200,"price":144.38,"value":28876.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":21996,"source":{"system":"sec-edgar","filing":"0001232524-17-000156","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000156/edgardoc.xml","form_type":"4"}},{"id":4255138,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-07-18T22:19:21.000Z","date":"2017-07-17","kind":"sale","acquired":false,"shares":200,"price":154.97,"value":30994.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 173 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2017."}],"balance_after":22196,"source":{"system":"sec-edgar","filing":"0001232524-17-000123","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000123/edgardoc.xml","form_type":"4"}},{"id":4278841,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-06-16T21:26:00.000Z","date":"2017-06-15","kind":"sale","acquired":false,"shares":200,"price":150.65,"value":30130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22223,"source":{"system":"sec-edgar","filing":"0001232524-17-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000121/edgardoc.xml","form_type":"4"}},{"id":4320584,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-05-15T21:26:52.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, May 11, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":2500,"derivative":{"exercise_price":155.18,"expiration_date":"2027-05-10","underlying":"Ordinary Shares","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001232524-17-000115","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000115/edgardoc.xml","form_type":"4"}},{"id":4320583,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-05-15T21:26:52.000Z","date":"2017-05-15","kind":"sale","acquired":false,"shares":200,"price":152.98,"value":30596.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22423,"source":{"system":"sec-edgar","filing":"0001232524-17-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000115/edgardoc.xml","form_type":"4"}},{"id":4320582,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-05-15T21:26:52.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of June 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":22623,"source":{"system":"sec-edgar","filing":"0001232524-17-000115","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000115/edgardoc.xml","form_type":"4"}},{"id":4329864,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-05-08T22:05:41.000Z","date":"2017-05-05","kind":"tax_withholding","acquired":false,"shares":939,"price":159.06,"value":149357.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":21623,"source":{"system":"sec-edgar","filing":"0001232524-17-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000100/edgardoc.xml","form_type":"4"}},{"id":4349489,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-04-19T21:26:38.000Z","date":"2017-04-17","kind":"sale","acquired":false,"shares":200,"price":152.56,"value":30512.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22562,"source":{"system":"sec-edgar","filing":"0001232524-17-000085","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000085/primary_doc.xml","form_type":"4"}},{"id":4382176,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-03-16T21:35:48.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":200,"price":137.89,"value":27578.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":22762,"source":{"system":"sec-edgar","filing":"0001232524-17-000079","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000079/edgardoc.xml","form_type":"4"}},{"id":4400078,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-06T23:53:00.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":17848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":17848,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":17848},"source":{"system":"sec-edgar","filing":"0001232524-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000060/edgardoc.xml","form_type":"4"}},{"id":4400077,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2017-03-06T23:53:00.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":902,"derivative":{"exercise_price":136.18,"expiration_date":"2027-03-01","underlying":"Ordinary Shares","underlying_shares":902},"source":{"system":"sec-edgar","filing":"0001232524-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000060/edgardoc.xml","form_type":"4"}},{"id":4400076,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-03-06T23:53:00.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":22962,"source":{"system":"sec-edgar","filing":"0001232524-17-000060","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000060/edgardoc.xml","form_type":"4"}},{"id":4413628,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-03-01T22:15:45.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":1024,"price":136.97,"value":140257.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":15462,"source":{"system":"sec-edgar","filing":"0001232524-17-000036","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000036/edgardoc.xml","form_type":"4"}},{"id":4442294,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-02-16T22:13:06.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":200,"price":134.55,"value":26910.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":16486,"source":{"system":"sec-edgar","filing":"0001232524-17-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000006/edgardoc.xml","form_type":"4"}},{"id":4488026,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2017-01-18T23:32:09.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":200,"price":115.93,"value":23186.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":16686,"source":{"system":"sec-edgar","filing":"0001232524-17-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252417000002/edgardoc.xml","form_type":"4"}},{"id":4518616,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2016-12-16T22:09:45.000Z","date":"2016-12-15","kind":"sale","acquired":false,"shares":200,"price":103.09,"value":20618.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 161 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2016."}],"balance_after":16886,"source":{"system":"sec-edgar","filing":"0001232524-16-000392","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252416000392/edgardoc.xml","form_type":"4"}},{"id":4552666,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2016-11-16T22:11:28.000Z","date":"2016-11-15","kind":"sale","acquired":false,"shares":200,"price":112.19,"value":22438.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":16925,"source":{"system":"sec-edgar","filing":"0001232524-16-000388","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252416000388/edgardoc.xml","form_type":"4"}},{"id":4578148,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2016-10-18T21:14:17.000Z","date":"2016-10-17","kind":"sale","acquired":false,"shares":200,"price":118.16,"value":23632.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":17125,"source":{"system":"sec-edgar","filing":"0001232524-16-000374","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252416000374/edgardoc.xml","form_type":"4"}},{"id":4598855,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial"}}],"security":"Ordinary Shares","published_at":"2016-09-20T21:34:21.000Z","date":"2016-09-19","kind":"sale","acquired":false,"shares":200,"price":126.17,"value":25234.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":17325,"source":{"system":"sec-edgar","filing":"0001232524-16-000364","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236514/000123252416000364/edgardoc.xml","form_type":"4"}}]}